Published in Annu Rev Med on January 01, 2006
Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol (2008) 5.83
EGFR signaling promotes TGFβ-dependent renal fibrosis. J Am Soc Nephrol (2011) 1.64
Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest (2011) 1.56
Kielin/chordin-like protein attenuates both acute and chronic renal injury. J Am Soc Nephrol (2013) 1.51
Phosphatidylinositol 3-kinase signaling determines kidney size. J Clin Invest (2015) 1.46
Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens (2013) 1.32
Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol (2008) 1.29
Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. J Am Soc Nephrol (2014) 1.15
Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts. PLoS One (2012) 1.14
The role of cell plasticity in progression and reversal of renal fibrosis. Int J Exp Pathol (2011) 1.08
Molecular targets for treatment of kidney fibrosis. J Mol Med (Berl) (2012) 1.06
Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy. Kidney Int (2013) 1.05
Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol (2007) 1.03
MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis. Physiol Genomics (2011) 1.02
Immune and inflammatory role in renal disease. Compr Physiol (2013) 0.97
Cytoglobin, a novel member of the globin family, protects kidney fibroblasts against oxidative stress under ischemic conditions. Am J Pathol (2010) 0.90
Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy. PLoS One (2013) 0.85
Renal macrophage infiltration is associated with a poor outcome in IgA nephropathy. Clinics (Sao Paulo) (2012) 0.84
Laser capture microdissection and multiplex-tandem PCR analysis of proximal tubular epithelial cell signaling in human kidney disease. PLoS One (2014) 0.84
Label-retaining cells in the kidney: origin of regenerating cells after renal ischemia. Clin Exp Nephrol (2007) 0.83
Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney. Int J Hypertens (2012) 0.83
Exercise attenuates renal dysfunction with preservation of myocardial function in chronic kidney disease. PLoS One (2013) 0.82
The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats. Int J Endocrinol (2016) 0.82
PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis. J Am Soc Nephrol (2012) 0.81
Invariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosis. PLoS One (2012) 0.81
Elevated serum 1,25(OH)2-vitamin D3 level attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction in kl/kl mice. Sci Rep (2014) 0.80
Association of a polymorphism of BTN2A1 with chronic kidney disease in community-dwelling individuals. Biomed Rep (2013) 0.80
The clinical characteristics of steroid responsive nephrotic syndrome of children according to the serum immunoglobulin E levels and cytokines. Yonsei Med J (2012) 0.80
Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy. PLoS One (2014) 0.78
Hemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension. Am J Physiol Renal Physiol (2014) 0.77
LRP-1: functions, signaling and implications in kidney and other diseases. Int J Mol Sci (2014) 0.77
Effect of methanolic fraction of Kalanchoe crenata on metabolic parameters in adriamycin-induced renal impairment in rats. Indian J Pharmacol (2012) 0.77
Anti-fibrotic effect of natural toxin bee venom on animal model of unilateral ureteral obstruction. Toxins (Basel) (2015) 0.77
Complement activation in progressive renal disease. World J Nephrol (2015) 0.77
Epigallocatechin-3-gallate attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis in mice. J Histochem Cytochem (2014) 0.76
Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additive. Front Pharmacol (2015) 0.76
Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy. BMC Nephrol (2016) 0.75
The Mechanisms of Human Renal Epithelial Cell Modulation of Autologous Dendritic Cell Phenotype and Function. PLoS One (2015) 0.75
Stop chronic kidney disease progression: Time is approaching. World J Nephrol (2016) 0.75
Mouse chromosome 2 harbors genetic determinants of resistance to podocyte injury and renal tubulointerstitial fibrosis. BMC Genet (2016) 0.75
Urinary collagen degradation products as early markers of progressive renal fibrosis. J Transl Med (2017) 0.75
Evaluation of "Dream Herb," Calea zacatechichi, for Nephrotoxicity Using Human Kidney Proximal Tubule Cells. J Toxicol (2016) 0.75
β2-microglobulin induces epithelial-mesenchymal transition in human renal proximal tubule epithelial cells in vitro. BMC Nephrol (2015) 0.75
2. Inflammation, Cytokines and Chemokines in Chronic Kidney Disease. EJIFCC (2009) 0.75
Association between Blood Dioxin Level and Chronic Kidney Disease in an Endemic Area of Exposure. PLoS One (2016) 0.75
CD11c⁺ CD8⁺ T Cells Reduce Renal Fibrosis Following Ureteric Obstruction by Inducing Fibroblast Apoptosis. Int J Mol Sci (2016) 0.75
Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease. Hypertension (2017) 0.75
Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition. Front Pharmacol (2017) 0.75
Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest (2003) 12.56
Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest (2002) 12.22
Stromal fibroblasts in cancer initiation and progression. Nature (2004) 11.69
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (2004) 10.23
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med (2007) 9.51
Biomarkers for epithelial-mesenchymal transitions. J Clin Invest (2009) 8.76
Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature (2012) 6.65
Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med (2003) 4.77
Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med (2010) 3.78
Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol (2010) 3.75
Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int (2002) 3.16
The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res (2003) 2.67
Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney Int (2005) 2.58
Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med (2009) 2.53
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene (2005) 2.35
Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int (2005) 2.34
Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med (2004) 2.10
A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest (2007) 1.93
Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens (2004) 1.92
EGFR signaling promotes TGFβ-dependent renal fibrosis. J Am Soc Nephrol (2011) 1.64
VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A (2011) 1.60
Dystroglycan in the diagnosis of FSGS. Clin J Am Soc Nephrol (2009) 1.60
Impaired T cell function in RANTES-deficient mice. Clin Immunol (2002) 1.60
Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol (2008) 1.54
Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis (2009) 1.51
Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int (2002) 1.50
Phosphatidylinositol 3-kinase signaling determines kidney size. J Clin Invest (2015) 1.46
Chronic kidney disease progression. J Am Soc Nephrol (2006) 1.40
Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol (2005) 1.39
Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res (2008) 1.36
Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J Biol Chem (2005) 1.35
Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol Cell Biol (2011) 1.32
Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice. Kidney Int (2004) 1.24
Increased hospital mortality in patients with bedside hippus. Am J Med (2008) 1.23
Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Kidney Int (2005) 1.17
Setting a trap for tissue fibrosis. Nat Med (2005) 1.11
New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol (2003) 1.09
Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy. J Am Soc Nephrol (2006) 1.08
Interventions to regulate ordering of serum magnesium levels: report of an unintended consequence of decision support. J Am Med Inform Assoc (2005) 1.03
Pathogenesis of Goodpasture syndrome: a molecular perspective. Semin Nephrol (2003) 0.99
Fibroblast expression of an IκB dominant-negative transgene attenuates renal fibrosis. J Am Soc Nephrol (2010) 0.97
Transcriptional networks in epithelial-mesenchymal transition. PLoS One (2011) 0.95
Dogs don't bark at parked cars. J Am Soc Nephrol (2013) 0.95
The fructose nation. J Am Soc Nephrol (2007) 0.88
Effects of performance-based compensation and faculty track on the clinical activity, research portfolio, and teaching mission of a large academic department of medicine. Acad Med (2003) 0.87
Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome. Kidney Int (2003) 0.86
Differential expression of type IV collagen isoforms in rat glomerular endothelial and mesangial cells. Biochem Biophys Res Commun (2002) 0.85
Effect of recommendations from reviewers suggested or excluded by authors. J Am Soc Nephrol (2011) 0.83
Volume depletion versus dehydration: how understanding the difference can guide therapy. Am J Kidney Dis (2011) 0.81
Author misrepresentation in the submission of redundant papers. J Am Soc Nephrol (2008) 0.81
Body fluid dynamics: back to the future. J Am Soc Nephrol (2011) 0.78
The role of fibroblasts in thymocyte-positive selection. J Immunol (2002) 0.77
The downside of a drug-crazed world. J Am Soc Nephrol (2006) 0.76
Finding new sea legs for urine proteomics. J Am Soc Nephrol (2009) 0.76
Web Surveillance for CKD. J Am Soc Nephrol (2012) 0.75
Author misrepresentation in the submission of redundant papers. Kidney Int (2008) 0.75